Federated Hermes’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,987
Closed -$14.7M 2281
2017
Q3
$14.7M Hold
19,987
0.04% 325
2017
Q2
$17.4M Hold
19,987
0.05% 293
2017
Q1
$17M Hold
19,987
0.05% 313
2016
Q4
$15.2M Hold
19,987
0.05% 319
2016
Q3
$16.4M Hold
19,987
0.05% 305
2016
Q2
$16.7M Sell
19,987
-14,700
-42% -$12.3M 0.05% 310
2016
Q1
$31.9M Hold
34,687
0.1% 175
2015
Q4
$35.7M Hold
34,687
0.11% 172
2015
Q3
$32.7M Sell
34,687
-5,381
-13% -$5.61M 0.11% 196
2015
Q2
$41.8M Buy
+40,068
New +$41.9M 0.13% 172

Other funds holding AGN.PRA

Federated Hermes's AGN.PRA Position: Q4 2017 in Review

Federated Hermes sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 19,987 shares — an estimated $14.7M sold.

Federated Hermes first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $41.8M in Q2 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Federated Hermes reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Federated Hermes sold 19,987 Allergan plc shares in Q4 2017, an estimated $14.7M.
  • Federated Hermes first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Federated Hermes's Allergan plc position peaked at $41.8M in Q2 2015.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.